| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.068 | 0.7 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.062 | 0.7 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |